Strata Skin Sciences Q3 EPS $(0.03) Beats $(0.04) Estimate, Sales $8.85M Beat $8.72M Estimate
Portfolio Pulse from totan@benzinga.com
Strata Skin Sciences (NASDAQ:SSKN) reported Q3 earnings with an EPS of $(0.03), surpassing the $(0.04) estimate. Sales reached $8.85M, exceeding the $8.72M estimate but marking a 5.96% decrease from the previous year's $9.41M.
November 14, 2023 | 9:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Strata Skin Sciences reported better-than-expected Q3 EPS and sales, but with a decrease in sales compared to last year.
Beating EPS and sales estimates is a positive signal to investors and could lead to a short-term increase in stock price. However, the year-over-year decrease in sales may temper some of the positive sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100